folic acid has been researched along with Hypertension, Pulmonary in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 5 (50.00) | 24.3611 |
2020's | 4 (40.00) | 2.80 |
Authors | Studies |
---|---|
Cunningham, G; Dikalova, A; Douglass, M; Fike, CD; Kaplowitz, MR; Summar, M; Zhang, Y | 1 |
Couper, J; MacKenzie, K; Peña, AS; Shaw, G; Wiltshire, E | 1 |
Ibrahimagić, OĆ; Kunić, S | 1 |
Bhattacharyya, A; Kaur, H; Kumar, S; Medhi, B; Prajapat, M; Prakash, A; Sarma, P | 1 |
Aiello, C; Boenzi, S; Cogo, P; Di Chiara, L; Dionisi-Vici, C; Iodice, FG; Monti, L | 1 |
Fenstad, ER; Frantz, RP; Kane, GC; Krowka, MJ; Lyle, MA; McGoon, MD; Swanson, KL | 1 |
Bertram, K; Chalupsky, K; Görlach, A; Kanchev, I; Kračun, D | 1 |
Gielis, JF; Lin, JY; Moens, AL; Schmidt, HH; Van Schil, PE; Wingler, K | 1 |
Lominadze, D; Metreveli, N; Qipshidze, N; Tyagi, N; Tyagi, SC | 1 |
Arroliga, AC; Jacobsen, DW; Mascha, EJ; Mustafa, M; Robinson, K; Sandur, S; Tewari, S | 1 |
1 review(s) available for folic acid and Hypertension, Pulmonary
Article | Year |
---|---|
Pathogenetic role of eNOS uncoupling in cardiopulmonary disorders.
Topics: Arginine; Atherosclerosis; Biopterins; Blood Pressure; Cardiac Surgical Procedures; Cell Adhesion; Endothelium, Vascular; Folic Acid; Humans; Hypertension, Pulmonary; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type III; Oxidation-Reduction; Oxygen; Reactive Oxygen Species; Vasodilation; Ventricular Remodeling | 2011 |
9 other study(ies) available for folic acid and Hypertension, Pulmonary
Article | Year |
---|---|
Folic acid, either solely or combined with L-citrulline, improves NO signaling and ameliorates chronic hypoxia-induced pulmonary hypertension in newborn pigs.
Topics: Animals; Citrulline; Drug Combinations; Female; Folic Acid; Hypertension, Pulmonary; Hypoxia; Male; Nitric Oxide; Pulmonary Artery; Signal Transduction; Swine; Vascular Resistance | 2021 |
High dose folic acid is a potential treatment for pulmonary hypertension, including when associated with COVID-19 pneumonia.
Topics: Administration, Inhalation; Animals; Betacoronavirus; Coronavirus Infections; COVID-19; Endothelium, Vascular; Enzyme Activation; Folic Acid; Humans; Hypertension, Pulmonary; Hypoxia; Mice; Nitric Oxide; Nitric Oxide Synthase Type III; Pandemics; Pneumonia, Viral; SARS-CoV-2; Tachyphylaxis | 2020 |
Comment on an article: "High dose folic acid is a potential treatment for pulmonary hypertension, including when associated with COVID-19 pneumonia".
Topics: COVID-19; Folic Acid; Humans; Hypertension, Pulmonary; Pandemics; SARS-CoV-2 | 2020 |
Folic acid as placebo in controlled clinical trials of hydroxychloroquine prophylaxis in COVID-19: Is it scientifically justifiable?
Topics: Angiotensin-Converting Enzyme 2; COVID-19; COVID-19 Drug Treatment; Folic Acid; Humans; Hydroxychloroquine; Hyperhomocysteinemia; Hypertension, Pulmonary; Methylenetetrahydrofolate Reductase (NADPH2); Models, Theoretical; Nitric Oxide Synthase Type III; Placebos; Protein Binding; Randomized Controlled Trials as Topic; Research Design | 2021 |
Cobalamin C defect presenting with isolated pulmonary hypertension.
Topics: Betaine; Brain; Child, Preschool; Diagnosis, Differential; Drug Therapy, Combination; Folic Acid; Genetic Carrier Screening; Humans; Hydroxocobalamin; Hypertension, Pulmonary; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Infant; Infant, Newborn; Injections, Intramuscular; Lung; Magnetic Resonance Imaging; Male; Metabolism, Inborn Errors; Neonatal Screening; Proto-Oncogene Proteins c-cbl; Pulmonary Artery; Tomography, X-Ray Computed; Vitamin B 12 Deficiency | 2013 |
Pulmonary Hypertension in Hereditary Hemorrhagic Telangiectasia.
Topics: Cardiac Catheterization; Female; Folic Acid; Follow-Up Studies; Humans; Hypertension, Pulmonary; Male; Middle Aged; Pulmonary Wedge Pressure; Retrospective Studies; Telangiectasia, Hereditary Hemorrhagic; Vascular Resistance; Ventricular Function, Right; Vinca Alkaloids | 2016 |
Folic Acid Promotes Recycling of Tetrahydrobiopterin and Protects Against Hypoxia-Induced Pulmonary Hypertension by Recoupling Endothelial Nitric Oxide Synthase.
Topics: Animals; Biopterins; Cardiotonic Agents; Cell Hypoxia; Cells, Cultured; Endothelium, Vascular; Folic Acid; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Mice, Inbred C57BL; Nitric Oxide; Nitric Oxide Synthase Type III; Pulmonary Artery; Superoxides; Tetrahydrofolate Dehydrogenase; Vascular Remodeling; Ventricular Pressure | 2015 |
Autophagy mechanism of right ventricular remodeling in murine model of pulmonary artery constriction.
Topics: Adaptor Proteins, Signal Transducing; Animals; Autophagy; Biomarkers; Disease Models, Animal; Folic Acid; Heart Ventricles; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Matrix Metalloproteinase 13; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Pulmonary Artery; Reactive Oxygen Species; Tissue Inhibitor of Metalloproteinase-4; Tissue Inhibitor of Metalloproteinases; Ventricular Remodeling; Vitamin B Complex | 2012 |
Association between hyperhomocysteinemia and primary pulmonary hypertension.
Topics: Adolescent; Adult; Aged; Case-Control Studies; Creatinine; Fasting; Female; Folic Acid; Humans; Hyperhomocysteinemia; Hypertension, Pulmonary; Logistic Models; Male; Middle Aged; Vitamin B 12 | 2003 |